top of page

WHAT WE DO
Advancing Surgical Planning
with Innovative AR Solutions
Pushing Beyond the Boundaries for Patient Safety
SKIA is dedicated to transforming surgical planning procedures through augmented reality-based solutions.
By reducing surgical deviation, we aim to create safer surgical environments for patients.
Our Goals
Surgical navigation for all specialties
Surgical navigation has only been available in the neurosurgical field. However, other surgical specialties also need navigational aid to improve surgical outcomes. With groundbreaking synergy between AI and AR, SKIA is dedicated to providing a comprehensive navigational solution for all surgeons.
Revolutionizing surgical navigation
The current setup procedure for surgical navigation systems is highly complicated and difficult to learn. Moreover, the conventional systems are heavy and require a large space. We have condensed our powerful navigation into a mobile device and made it intuitive to use. The fast mobility of our system allows surgical navigation to be used in many of the emergency cases where conventional systems cannot enter.
Empower patients with knowledge
Imagine being diagnosed with a deep-seated brain tumor, a condition that's hard to fully grasp. SKIA transforms this experience by allowing patients to visualize their internal anatomy and understand the surgical approach in detail. By empowering patients with accessible knowledge, we help them make more informed and confident decisions about their health.
History
We consistently deliver impactful solutions to benefit both patients and surgeons
May
Starting Confirmatory Clinical Trial for SKIA Breast
Feb
Project μ with Mayo Clinic
Jan
Started Clinical Trial for SKIA Head in Korea
Meet Our Team
Our team establishes new frontiers and pushes boundaries, driving continuous progress and innovation
to harness the full potential of artificial intelligence and augmented reality.

Jongmyoung Lee
Chief Executive Officer

Hyuk Kwon
Chief Operating Officer

Dr. Junwoo Lee
Chief Medical Officer

Seungwon Na
Chief Technical Officer

Prof. Jeongjin Lee
AI R&D Leader

Abhishek Bandaru
COO, SKIA India

Dr. Manjula Anagani
Clinical Advisor, SKIA India
Main Investors
A total of 10 million USD has been secured.
Series A-B Bridge Round has recently closed.

Bluepoint Partners

Golden Oak Invetment

TS Invetment

Albatross Investment

KVIC

AVentures

Industrial Bank of Korea

SK Securities

Hyundai Pharm
bottom of page